Soleus Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,900,000
Closed -$354M 116
2025
Q4
$354M Buy
2,900,000
+1,750,000
+152% +$201M 13.04% 1
2025
Q3
$115M Buy
1,150,000
+400,000
+53% +$36M 5.8% 4
2025
Q2
$62.2M Buy
+750,000
New +$59.8M 4.12% 4
2024
Q2
Sell
-2,200,000
Closed -$209M 114
2024
Q1
$209M Buy
+2,200,000
New +$204M 15.49% 1
2022
Q1
Sell
-1,292,000
Closed -$145M 79
2021
Q4
$145M Buy
+1,292,000
New +$156M 14.48% 1
2021
Q1
Sell
-2,825,000
Closed -$398M 82
2020
Q4
$398M Buy
+2,825,000
New +$362M 52.48% 1

Other funds holding XBI